Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-Driven Drug Discovery Platform

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.

Related Keywords

Murat Tunaboylu , Megan Craig , Ted Parkinson , Antiverse Ltd , Development Bank , Fluorescence Activated Cell Sorting , Kadmos Capital , Tomorrow Scale , Tensor Ventures , Deep Science Ventures ,